<p>Robert J. Bitterman, Chairman, President, and CEO of Phio Pharmaceuticals Corp., reported the acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-008639), on November 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

PHIO

<p>Phio Pharmaceuticals CEO Robert J. Bitterman has acquired common shares of the company. The acquisition was reported through EDGAR by Phio Pharmaceuticals Corp. on November 24, 2025. This information is for informational purposes and not financial advice.</p>

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares